Main Menu

News and features 

Read the latest stories about our world-leading research, science, fundraising and philanthropy. 

To find out more, you can contact our media team, follow us on social media or visit our press release archive.


Sign up for our newsletters


News

Researchers identify what drives PARP inhibitor resistance in advanced breast cancer 08
May
2024

Researchers at The Institute of Cancer Research, London, have increased our understanding of how a cancer drug called a PARP inhibitor stops working in women with breast cancer that has spread. This research could ultimately help predict who’s more likely to respond to these drugs, and could lead to more effective ways to treat the disease. Find out more

New trial finds radiotherapy combined with hormone therapy can help some advanced prostate cancer patients avoid chemotherapy 08
May
2024

Radiotherapy can be used alongside hormone treatment, delaying the need for chemotherapy and therefore significantly protecting their quality of life for some patients with advanced prostate cancer, according to researchers from The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London. Find out more

Immune cells hunt down cancer around the body – discovery could lead to personalised treatments for advanced breast cancer 02
May
2024

Scientists have discovered the key features of immune B cells which make them successful at targeting tumours – including when cancer has spread to a different part of the body. Find out more

See all news articles

Features

Scientific achievements of 2023 05
Dec
2023

We've selected a range of discoveries from the academic year that highlight the quality and breadth of our basic, translational and clinical research. Find out more

Untapping the full potential of immunotherapies for more people with cancer 06
Jun
2023

Immunotherapy works by sparking the body’s own immune system into action against tumours. It has become a first-choice treatment for some types of cancer, and now there are exciting opportunities to unlock its benefits for more patients through research. Jane Shepley explores the story behind immunotherapy and how we can untap its potential. Find out more

Over a decade of abiraterone: the drug that revolutionised advanced prostate cancer care 14
Mar
2023

This Prostate Cancer Awareness Month, we’re celebrating over 10 years since abiraterone was first recommended by NICE in England as a treatment for advanced prostate cancer. We share the story of the drug’s discovery, how a landmark trial changed the way advanced prostate cancer is treated today, and what the drug has meant for patients who are currently treated with it. Find out more

See all feature articles